Arvinas Stock Today
| ARVN Stock | USD 32.54 1.46 4.29% |
Performance0 of 100
| Odds Of DistressLess than 46
|
Arvinas is selling at 32.54 as of the 24th of April 2024; that is -4.29 percent decrease since the beginning of the trading day. The stock's open price was 34.0. Arvinas has 46 percent odds of going through some form of financial distress in the next two years and has generated negative returns to investors over the last 90 days. Equity ratings for Arvinas are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 25th of March 2024 and ending today, the 24th of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 27th of September 2018 | Category Healthcare | Classification Health Care |
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Arvinas, Inc. was founded in 2013 and is based in New Haven, Connecticut. Arvinas operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 68.31 M outstanding shares of which 8.6 M shares are presently shorted by private and institutional investors with about 10.9 trading days to cover. More on Arvinas
Moving together with Arvinas Stock
| 0.62 | EFTR | Effector Therapeutics Financial Report 14th of May 2024 | PairCorr |
Moving against Arvinas Stock
| 0.72 | ACB | Aurora Cannabis Trending | PairCorr |
| 0.69 | CGC | Canopy Growth Corp Trending | PairCorr |
| 0.64 | ELYM | Eliem Therapeutics | PairCorr |
| 0.44 | XFOR | X4 Pharmaceuticals Earnings Call Next Week | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Financial Report 3rd of May 2024
Arvinas Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Arvinas' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Arvinas or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| President CEO, Director | John Houston | ||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Biotechnology, NASDAQ Health Care, Health Care, Pharmaceuticals, Biotechnology, Healthcare (View all Sectors) | ||||
| Average Analyst Recommendation Analysts covering Arvinas report their recommendations after researching Arvinas' financial statements, talking to executives and customers, or listening in on Arvinas' conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Arvinas. The Arvinas consensus assessment is calculated by taking the average forecast from all of the analysts covering Arvinas. | |||||
Arvinas' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Arvinas' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Arvinas' financial leverage. It provides some insight into what part of Arvinas' total assets is financed by creditors.
| |||||
Arvinas (ARVN) is traded on NASDAQ Exchange in USA. It is located in 5 Science Park, New Haven, CT, United States, 06511 and employs 445 people. Arvinas is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.32 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Arvinas's market, we take the total number of its shares issued and multiply it by Arvinas's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Arvinas conducts business under Pharmaceuticals sector and is part of Health Care industry. The entity has 68.31 M outstanding shares of which 8.6 M shares are presently shorted by private and institutional investors with about 10.9 trading days to cover.
Arvinas currently holds about 1.27 B in cash with (347.8 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 23.87.
Check Arvinas Probability Of Bankruptcy
Ownership AllocationArvinas holds a total of 68.31 Million outstanding shares. The majority of Arvinas outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Arvinas to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Arvinas. Please pay attention to any change in the institutional holdings of Arvinas as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Arvinas Ownership Details
Arvinas Stock Price Odds Analysis
Contingent on a normal probability distribution, the odds of Arvinas jumping above the current price in 90 days from now is about 97.0%. The Arvinas probability density function shows the probability of Arvinas stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 2.3339. This suggests as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Arvinas will likely underperform. Additionally, arvinas has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Arvinas to move above the current price in 90 days from now is about 97.0 (This Arvinas probability density function shows the probability of Arvinas Stock to fall within a particular range of prices over 90 days) .
Arvinas Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Arvinas that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Arvinas' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Arvinas' value.| Instituion | Recorded On | Shares | |
| New Leaf Venture Partners, L.l.c. | 2023-12-31 | 1.3 M | |
| State Street Corporation | 2023-12-31 | 1.2 M | |
| Geode Capital Management, Llc | 2023-12-31 | 1.1 M | |
| Commodore Capital Lp | 2023-12-31 | 1000 K | |
| Paradigm Biocapital Advisors Lp | 2023-12-31 | 931.3 K | |
| Norges Bank | 2023-12-31 | 877.7 K | |
| Adage Capital Partners Gp Llc | 2023-12-31 | 789.5 K | |
| Morgan Stanley - Brokerage Accounts | 2023-12-31 | 693.5 K | |
| Goldman Sachs Group Inc | 2023-12-31 | 658.9 K | |
| Ecor1 Capital, Llc | 2023-12-31 | 6.7 M | |
| Blackrock Inc | 2023-12-31 | 5.4 M |
Arvinas Historical Income Statement
Arvinas Income Statement is one of the three primary financial statements used for reporting Arvinas's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Arvinas revenue and expense. Arvinas Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Arvinas' Cost Of Revenue is very stable compared to the past year. As of the 24th of April 2024, Total Operating Expenses is likely to grow to about 497 M, while Tax Provision is likely to drop about 5.7 M. View More FundamentalsArvinas Stock Against Markets
Picking the right benchmark for Arvinas stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Arvinas stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Arvinas is critical whether you are bullish or bearish towards Arvinas at a given time. Please also check how Arvinas' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Arvinas without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Price Ceiling Movement Now
Price Ceiling MovementCalculate and plot Price Ceiling Movement for different equity instruments |
| All Next | Launch Module |
Arvinas Corporate Directors
Arvinas corporate directors refer to members of an Arvinas board of directors. The board of directors generally takes responsibility for the Arvinas' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Arvinas' board members must vote for the resolution. The Arvinas board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Leslie Norwalk | Director | Profile | |
| Edward Kennedy | Independent Director | Profile | |
| Jakob Loven | Independent Director | Profile | |
| Bradley Margus | Independent Director | Profile |
How to buy Arvinas Stock?
Before investing in Arvinas, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Arvinas. To buy Arvinas stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Arvinas. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Arvinas stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Arvinas stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Arvinas stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Arvinas, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Arvinas Stock please use our How to Invest in Arvinas guide.
Already Invested in Arvinas?
The danger of trading Arvinas is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Arvinas is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Arvinas. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Arvinas is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Arvinas offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Arvinas' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Arvinas Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Arvinas Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Arvinas. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. To learn how to invest in Arvinas Stock, please use our How to Invest in Arvinas guide.You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Complementary Tools for Arvinas Stock analysis
When running Arvinas' price analysis, check to measure Arvinas' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arvinas is operating at the current time. Most of Arvinas' value examination focuses on studying past and present price action to predict the probability of Arvinas' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arvinas' price. Additionally, you may evaluate how the addition of Arvinas to your portfolios can decrease your overall portfolio volatility.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |
Is Arvinas' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arvinas. If investors know Arvinas will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arvinas listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (6.62) | Revenue Per Share 1.414 | Quarterly Revenue Growth 0.042 | Return On Assets (0.20) | Return On Equity (0.60) |
The market value of Arvinas is measured differently than its book value, which is the value of Arvinas that is recorded on the company's balance sheet. Investors also form their own opinion of Arvinas' value that differs from its market value or its book value, called intrinsic value, which is Arvinas' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arvinas' market value can be influenced by many factors that don't directly affect Arvinas' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Arvinas' value and its price as these two are different measures arrived at by different means. Investors typically determine if Arvinas is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arvinas' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.